Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Saad Z. Usmani, Vania T. M. Hungria, Xavier Leleu, Hans C. Lee, Faith E. Davies, Caitlin L. Costello, Robert M Rifkin, Katja Weisel, Ajai Chari, Noemi Puig, Mario Boccadoro, Gordon Cook, Jesus G. Berdeja, Jeffrey A Zonder, Michael A. Thompson, Rafat Abonour, Jorge Vela-Ojeda, Roman Hajek, Andrew Spencer, Jim Omel, Brittany Demers, Dorothy Romanus, Kaili Ren, Tomas Skacel, Dawn Marie Stull, Evangelos Terpos
Institutions: Levine Cancer Institute, São Germano Oncologia, Centre Hospitalier Universitaire de Poitiers, The University of Texas MD Anderson Cancer Center, University of Arkansas Medical Center, University of Arkansas for Medical Sciences, University of California San Diego, Moores Cancer Center, Rocky Mountain Cancer Centers, Universitätsklinikum Tübingen, Icahn School of Medicine at Mount Sinai, Complejo Hospitalario de Salamanca, University of Turin, Leeds Teaching Hospitals NHS Trust, National Institute for Health and Care Research, Tennessee Oncology, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Aurora Health Care, Indiana University School of Medicine, Mexican Social Security Institute, Centro Médico Nacional La Raza, University Hospital Ostrava, The Alfred Hospital, Monash University, Takeda Oncology (United States), National and Kapodistrian University of Athens
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2899308628